Clinical Trials in AML Seek to Eliminate ‘Leftover’ Cells That Persist After Treatment

Over the last decade, significant strides have been made in understanding the molecular underpinnings of acute myelogenous leukemia (AML) in adults, which has led to better drugs and better treatment outcomes for patients. This shifting landscape now makes it possible for cancer researchers and providers to ask, “How can we do better?” Dana-Farber medical oncologist … Read more

State Rep Stays Committed to Constituents During Pancreatic Cancer Treatment 

Ann-Margaret Ferrante likes a good fight. The daughter and granddaughter of Gloucester, Mass. fishermen has long devoted herself to helping those in and around her hardy hometown, first as a lawyer, and since 2009 as a member of the Massachusetts House of Representatives.   For the last three years, however, Ferrante has had to balance her … Read more

Breast Cancer and Young People of Asian and Pacific Islander (AAPI) Descent: What You Need to Know 

Between 2000 and 2021, breast cancer rates in people under 50 of Asian or Pacific Islander decent rose by nearly 50%, from 36 to 55 cases per 100,000, with sharper increases between 2020 and 2021. Rates of breast cancer in young people are known to be rising in general, but this rate increase, according to … Read more

What You Need to Know About Rising Pancreatic Cancer Rates 

A recent analysis of pancreatic cancer statistics in the United States has found that the incidence of pancreatic cancer is increasing faster in younger adults than among older adults. Though this finding is cause for further investigation, the incidence overall remains low.   “This is still a rare cancer in young people,” says Asaf Maoz, MD, … Read more

Building In Access from the Start: Five Efforts by the Centers for Early Detection and Interception 

Dana-Farber’s Centers for Early Detection and Interception, founded in 2023, aim to detect cancer early, when there is a greater chance of treating and curing that cancer. The Centers also serve as a hub for research, with investigators seeking to better understand cancer risk and how it can be reduced.  “Dana-Farber has always been the … Read more

Study Highlights Unique Needs of Young Adults with Colorectal Cancer

Clinicians and researchers have recognized a disturbing trend in recent years: colorectal cancer (CRC) in young people is skyrocketing. In individuals under the age of 50, the incidence of CRC has increased about 2% each year since the 1990s, and, according to the American Cancer Society, is now the leading cause of death in males … Read more

Dana-Farber Researchers ‘Hijack’ Gut Bacteria to Design Novel Form of Cancer Immunotherapy

Tumors are experts at dodging the immune system. This evasion not only helps to ensure their survival, but also has important implications for treatment. That’s because cancer therapies that harness the immune system, such as CAR T-cells or other engineered immune cells, are often rendered ineffective by the milieu that surrounds a tumor — known … Read more

Study of Inherited Prostate Cancer Genetics in Africa Highlights Importance of Research

The genetic landscape of prostate cancer susceptibility in Africa is, like the continent itself, a picture of sweeping diversity, the largest study of the phenomenon concludes.  The findings, published in the journal Nature Genetics, are an important step in unravelling why prostate cancer rates are highest in men of African descent, whether they live in … Read more

With Dana-Farber’s Help, Grandmother Becomes Great Grandmother 

Six years ago, Ina Kornetsky was looking forward to a new chapter in her life. The lifelong teacher had most recently worked with older adults before retiring, and she had a deep understanding of the kind of life she wanted as she approached 90. She was preparing to move from Stoughton, Mass. into a continuing … Read more

Patient Takes Steps Toward Proactive Care Following Three Cancer Diagnoses 

Elizabeth Johnston, then 37, was healthy and busy with two young children and a blossoming career running a public relations firm in Connecticut. One of her clients is the Hartford Marathon Foundation and in 2015, she decided to start running smaller stretches herself.   “I was in the best shape of my life,” Johnston recalls.   Little … Read more

For Neurodiverse Patient, New Program Provides Comfort, Allies 

Naomi Dogan, PhD, still remembers a visit to the hospital earlier this year for blood work, after joining a clinical trial for patients incurring symptoms related to polycythemia vera — one of a group of rare blood disorders known as myeloproliferative neoplasms (MPNs).   In a far corner of the large room a machine quietly hummed … Read more